- Business
- CompuGroup Medical SE & Co. KGaA develops and provides e-health software solutions that support medical and organizational processes for healthcare professionals worldwide; its core offerings include ambulatory information systems (AIS) such as practice management software for physicians, medical care centers, and networks; pharmacy information systems (PCS) featuring integrated administrative, billing, and inventory applications; hospital information systems (HIS) delivering clinical and administrative tools for inpatient care; laboratory information systems (LIS); electronic health records (EHR); revenue cycle management services; EDI clearinghouse solutions; and AI-powered innovations like ambient AI assistants, CG1, and tools for processing faxes and scans. The company operates through these segments to serve doctors, dentists, pharmacists, hospitals, laboratories, social welfare institutions, insurers, and pharmaceutical firms, with a presence in 19 countries including Germany, Austria, USA, France, Italy, Poland, Spain, and others, and solutions deployed in 60 countries. Founded in 1987 and headquartered in Koblenz, Germany, CompuGroup Medical employs over 8,700 staff and reported EUR 1.19 billion in revenue for 2023. In recent developments, the company entered a strategic partnership with CVC Capital Partners in December 2024, culminating in CVC's voluntary public tender offer at EUR 22.00 per share, completion of the takeover in May 2025, and delisting from the stock exchange on June 24, 2025, while the founding Gotthardt family retains majority control to fuel innovation in cloud-based, AI-driven products and inorganic growth; it also pursued acquisitions like Freo and AmbulApps in 2024 to bolster market position, enhanced recurring revenues to nearly 75% of total with 5% growth, and advanced electronic prescription capabilities in Germany, issuing 30% of national e-prescriptions.